Bulk Inquiry
JNJ 47965567
- Soluble in DMSO
- MF: C28H32N4O2S
- MW: 488.64
Description
JNJ-47965567 is a potent, selective and brain-penetrant antagonist of the ATP-gated P2X7 receptor. Reported pKi values are 7.9 at human P2X7, 7.9 at rat P2X7 and 6.9 in a human whole-blood assay.
JNJ-47965567 blocks P2X7-dependent pore formation, inflammasome-associated cytokine release and neuroimmune signaling and has suitable pharmacokinetic properties for in vivo target-occupancy studies. It is used to investigate P2X7 function in microglia, neuroinflammation, pain and inflammatory disease models.
Key Features
- Potent P2X7 receptor antagonist
- pKi: 7.9 at human and rat P2X7
- Brain-penetrant
- Suitable for in vivo pharmacodynamic studies
- Blocks P2X7-dependent inflammatory signaling
Applications
- P2X7 receptor pharmacology
- Microglial activation studies
- Inflammasome and cytokine-release assays
- Neuroinflammation models
- Pain and inflammatory disease research
More Information
| Parent CAS No. | 1428327-31-4 |
|---|---|
| Chemical Name | N-((4-(4-Phenylpiperazin-1-yl)tetrahydro-2H-pyran-4-yl)methyl)-2-(phenylthio)nicotinamide |
| SMILES | C1C=C(C(NCC2(N3CCN(C4C=CC=CC=4)CC3)CCOCC2)=O)C(SC2C=CC=CC=2)=NC=1 |
| MFCD | MFCD28334214 |
| InChi | InChI=1S/C28H32N4O2S/c33-26(25-12-7-15-29-27(25)35-24-10-5-2-6-11-24)30-22-28(13-20-34-21-14-28)32-18-16-31(17-19-32)23-8-3-1-4-9-23/h1-12,15H,13-14,16-22H2,(H,30,33) |
| InChiKey | XREFXUCWSYMIOG-UHFFFAOYSA-N |
| CID | 66553218 |
| Short Description | P2X7 antagonist |


